Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: An open-label, 8-week, methylphenidate-controlled trial

Iris Cohen-Yavin, Roni Yoran-Hegesh, Rael Strous, Moshe Kotler, Avraham Weizman, Boris Spivak

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: An open-label, 8-week, methylphenidate-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences